FMC (NYSE:FMC) Stock

FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.

BBWI

DENN


When the stock market seems to be on a roll, trending ever so higher without much interruption, there comes a point when the excess returns begin to concentrate in a single area while leaving most other worthy names

Small-Cap Surge: 3 Stocks Ready to Ride the Market Rotation

Computer,Parts,Close,Up.,Computer,Chip.,Technology

Earnings

News

Markets

AMZN

ANET

ARKK

BABA

BEKE

INTC

MPLX

MSFT

ORCL

Citigourp Global Markets 2% Protected Notes Linked To The Djia

QCOM

UBER

David Tepper&#39;s hedge fund, Appaloosa LP, has made significant alterations to its portfolio.

David Tepper&#39;s Appaloosa Revamps Portfolio, Cuts Down On Semiconductor Stocks

Nike Inc.

Downgrades

Analyst Ratings

Trading Ideas

XPEV

This Nike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

FMC Corp

FRMRS&MER BNCORP LODI CA by Farmers & Merchants Bancorp

Farmers & Merchants Bancorp

Federal Home Loan Mortgage Corp

Northern Lights Fund Trust IV FM Compounders Equity ETF

FRESENIUS MED CARE AG ORD by Fresenius Medical Care AG

Fresenius Medical Care AG

FM Focus Equity ETF

FORAN MINING CORP by Foran Mining Corporation

Foran Mining Corp

Keybanc analyst Aleksey Yefremov maintains FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) with a Overweight and lowers the price target from $55 to $51.

Price Target

Keybanc Maintains Overweight on FMC, Lowers Price Target to $51

In a recent shift of investment strategy,&nbsp;David Tepper&#8216;s hedge fund,&nbsp;Appaloosa LP, has made significant alterations to its portfolio. 
What Happened: The firm&#8217;s latest 13F filing reveals a reduction in semiconductor holdings, while stakes in other tech stocks, including&nbsp;Oracle Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) and the&nbsp;ARK Innovation ETF (ARKK), have been increased.
Appaloosa LP, during&nbsp;the fourth quarter of 2023,&nbsp;purchased&nbsp;1.3 million shares in Oracle&nbsp;Corp worth approximately&nbsp;$140 million and a call&nbsp;option for nearly&nbsp;2.6 million shares of the&nbsp;ARK Innovation ETF valued at over $133 million. The hedge fund also established&nbsp;new positions in FMC Corp.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) and General Motors Co.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>).
Investments were also made&nbsp;in the home improvement, construction,&nbsp;and building materials sectors, with the acquisition of shares in firms such as Masco Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAS#NYSE">MAS</a>), Mohawk Industries Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MHK#NYSE">MHK</a>), and Owens Corning (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OC#NYSE">OC</a>).
According to a report <a href="https://www.investopedia.com/tepper-appaloosa-13f-q4-2023-8580346">by </a>Investopedia, Appaloosa reduced its positions in&nbsp;several tech firms, including Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>),&nbsp;Alphabet Class C stock (GOOG),&nbsp;Qualcomm Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>), Uber Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>), and&nbsp;Taiwan Semiconductor Manufacturing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>).&nbsp;The largest sell-off involved&nbsp;nearly 1.7 million shares of&nbsp;Intel Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>).
Also Read: <a href="https://www.benzinga.com/markets/equities/25/02/43746268/david-tepper-rausing-family-boost-nvidia-holdings-ahead-of-stock-volatility">David Tepper, Rausing Family Boost Nvidia Holdings Ahead Of Stock Volatility</a>
Outside of tech, the fund sold off shares in KE Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEKE#NYSE">BEKE</a>), Macy&#8217;s Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/M#NYSE">M</a>), and PDD Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>). On the flip side, Appaloosa added to its existing positions in Caesars Entertainment Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CZR#NASDAQ">CZR</a>), MPLX LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPLX#NYSE">MPLX</a>), Alibaba Group Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>), Amazon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), and Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>).
The hedge fund also&nbsp;exited two positions entirely in&nbsp;the fourth quarter, selling off&nbsp;shares of Arista Networks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NYSE">ANET</a>)&nbsp;and Enterprise Products Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPD#NYSE">EPD</a>).
Why It Matters: Appaloosa&#8217;s portfolio reshuffle indicates a strategic shift towards diversification. The reduction in semiconductor holdings comes amidst a global chip shortage, potentially signaling a cautious approach. 
The increased stakes in other tech stocks and the home improvement sector suggest a focus on industries that have shown resilience during the pandemic. The fund&#8217;s&nbsp;new positions in FMC Corp.&nbsp;and General Motors Co. indicate a bet on the agrochemical and automotive industries, respectively. 
The sell-offs, on the other hand, might reflect an attempt to mitigate risks associated with specific stocks or sectors.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/earnings-beats/25/02/43740996/palo-alto-analysts-optimistic-on-revenue-growth-expanding-market-share" target="_blank" rel="noreferrer noopener">Palo Alto Analysts Optimistic On Revenue Growth, Expanding Market Share</a></li>
</ul>
Image: Shutterstock

David Tepper's Appaloosa Revamps Portfolio, Cuts Down On Semiconductor Stocks

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Morgan Stanley analyst Dara Mohsenian downgraded the rating for e.l.f. Beauty, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>) from Overweight to Equal-Weight and lowered the price target from $153 to $70. e.l.f. Beauty shares closed at $88.49 on Thursday. <a href="https://www.benzinga.com/quote/ELF/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan analyst Jeffrey Zekauskas downgraded Air Products and Chemicals, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APD#NYSE">APD</a>) from Overweight to Neutral and lowered the price target from $345 to $320. Air Products shares closed at $328.13 on Thursday. <a href="https://www.benzinga.com/quote/APD/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Macquarie analyst Eugene Hsiao downgraded the rating for XPeng Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) from Outperform to Neutral and announced a price target of $18. XPeng shares closed at $17.10 on Thursday. <a href="https://www.benzinga.com/quote/XPEV/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup analyst Paul Lejuez downgraded NIKE, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) from Buy to Neutral and lowered the price target from $102 to $72. Nike shares closed at $71.74 on Thursday. <a href="https://www.benzinga.com/quote/NKE/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>UBS analyst Joshua Spector downgraded the rating for FMC Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) from Buy to Neutral and slashed the price target from $66 to $38. FMC shares closed at $35.66 on Thursday. <a href="https://www.benzinga.com/quote/FMC/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying NKE stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="587" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/07102242/image-67-1024x587.png" alt="" class="wp-image-772065" style="width:760px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/07102242/image-67-1024x587.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/07102242/image-67-300x172.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/07102242/image-67-768x440.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/07102242/image-67.png 1111w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43558786/how-to-earn-500-a-month-from-mcdonalds-stock-ahead-of-q4-earnings">How To Earn $500 A Month From McDonald&#8217;s Stock Ahead Of Q4 Earnings</a></li>
</ul>

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the materials sector.
<h3 class="wp-block-heading">Dow Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOW#NYSE">DOW</a>)</h3>
<ul>
<li>Dividend Yield: 7.22%</li>
<li>JP Morgan analyst Jeffrey Zekauskas maintained an Overweight rating and cut the price target from $47 to $40 on Jan. 31, 2025. This analyst has an accuracy rate of 68%.</li>
<li>Morgan Stanley analyst Vincent Andrews maintained an Equal-Weight rating and cut the price target from $46 to $43 on Jan. 31, 2025. This analyst has an accuracy rate of 79%.</li>
<li>Recent News: On Jan. 30, Dow reported worse-than-expected fourth-quarter financial results.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent020725&amp;t=be2bearmibe3na1">DOW news</a>. </li>
</ul>
<figure class="wp-block-image is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent020725&amp;t=be2bearmibe3na1"><img decoding="async" src="blob:https://editorial.benzinga.com/02eef5cb-c127-47b9-8dc3-264a4b203ec8" alt="" style="width:528px;height:auto" /></a></figure>
<h3 class="wp-block-heading">FMC Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>)</h3>
<ul>
<li>Dividend Yield: 6.51%</li>
<li>Morgan Stanley analyst Vincent Andrews maintained an Equal-Weight rating and cut the price target from $70 to $46 on Feb. 5, 2025. This analyst has an accuracy rate of 79%.</li>
<li>Citigroup analyst Patrick Cunningham maintained a Neutral rating and raised the price target from $55 to $61 on Jan. 29, 2025. This analyst has an accuracy rate of 61%.</li>
<li>Recent News: On Feb. 4, FMC issued weak guidance.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent020725&amp;t=be2bearmibe3na1">FMC news</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent020725&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="823" height="787" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/07042626/image-2-16.png" alt="" class="wp-image-771200" style="width:604px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/07042626/image-2-16.png 823w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/07042626/image-2-16-300x287.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/07042626/image-2-16-768x734.png 768w" sizes="(max-width: 823px) 100vw, 823px" /></a></figure>
<h3 class="wp-block-heading">Huntsman Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>)</h3>
<ul>
<li>Dividend Yield: 5.80%</li>
<li>Mizuho analyst Kieran De Brun maintained a Neutral rating and lowered the price target from $23 to $21 on Jan. 7, 2025. This analyst has an accuracy rate of 65%.</li>
<li>Citigroup analyst Patrick Cunningham maintained a Neutral rating and lowered the price target from $22 to $19 on Dec. 18, 2024. This analyst has an accuracy rate of 61%.</li>
<li>Recent News: Huntsman will release its fourth quarter 2024 financial results after the closing bell on Feb. 17.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent020725&amp;t=be2bearmibe3na1">HUN news</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent020725&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="906" height="802" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/07042722/image-65.png" alt="" class="wp-image-771201" style="width:612px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/07042722/image-65.png 906w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/07042722/image-65-300x266.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/07042722/image-65-768x680.png 768w" sizes="(max-width: 906px) 100vw, 906px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43526669/jim-cramer-says-dont-buy-this-financial-stock-at-this-level-let-it-come-in">Jim Cramer Says Don&#8217;t Buy This Financial Stock At This Level: &#8216;Let It Come In&#8217;</a></li>
</ul>

Dividends

Pre-Market Outlook

Wall Street's Most Accurate Analysts Give Their Take On 3 Materials Stocks With Over 5% Dividend Yields

UBS analyst Joshua Spector downgrades FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) from Buy to Neutral and lowers the price target from $66 to $38.

UBS Downgrades FMC to Neutral, Lowers Price Target to $38

11 analysts have shared their evaluations of FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">7</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for FMC, presenting an average target of $56.64, a high estimate of $69.00, and a low estimate of $46.00. A decline of 16.71% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2025/1738778472_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
A clear picture of FMC's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Steve Byrne</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$48.00</td>
<td>$61.00</td>
</tr>
<tr>
<td>Joel Jackson</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$50.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Vincent Andrews</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$46.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$47.00</td>
<td>$78.00</td>
</tr>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$61.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Benjamin Theurer</td>
<td>Barclays</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$65.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Steve Byrne</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$61.00</td>
<td>$63.00</td>
</tr>
<tr>
<td>Christopher Parkinson</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$55.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Aleksey Yefremov</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$69.00</td>
<td>$79.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$66.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$55.00</td>
<td>$70.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to FMC. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of FMC compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for FMC's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into FMC's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/FMC/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on FMC analyst ratings.</a>
<h2>All You Need to Know About FMC</h2>
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.
<h3>Financial Milestones: FMC's Journey</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: FMC's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of 8.5%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Materials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 6.08%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): FMC's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.41% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): FMC's ROA stands out, surpassing industry averages. With an impressive ROA of 0.53%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: FMC's debt-to-equity ratio stands notably higher than the industry average, reaching 0.88. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>What Are Analyst Ratings?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

The Analyst Verdict: FMC In The Eyes Of 11 Experts

FMC Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) shares plunged on Wednesday after the company reported fourth-quarter results on Tuesday and <a href="https://www.benzinga.com/quote/FMC/analyst-ratings" target="_blank" rel="noreferrer noopener">analysts downgraded the stock.</a>
FMC reported adjusted EPS of $1.79, beating the $1.60 estimate, while sales of $1.22 billion missed <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/n43478114/fmc-corporation-announces-2024-fourth-quarter-and-full-year-results-provides-2025-outlook" rel="noreferrer noopener">the consensus of $1.31 billion</a>.
The company expects first-quarter adjusted EPS of $0.05 &#8211; $0.15 (vs. $0.94 estimate) and revenue of $750 million &#8211; $800 million<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener"> (vs. street view of $1.031 billion)</a>.
For FY25, FMC forecasts adjusted EPS of $3.26 &#8211; $3.70 (vs. $4.38 est.) and revenue of $4.15 billion &#8211; $4.35 billion (vs. consensus of $4.406 billion).
BofA Securities analyst Steve Byrne downgraded the company from Neutral to Underperform and cut the price forecast from $61 to $48.
The analyst cited a weak first-quarter outlook, raising doubts about full-year volume growth assumptions and increased competition in diamides as key concerns.
Additional concerns includes limited EBITDA growth despite an easy 2024 comparable and renewed worries over leverage and dividend sustainability, per the analyst.
Byrne writes that he is at the upper end of FMC&#8217;s 2025 EBITDA guidance and project adjusted free cash flow of $369 million (within the company&#8217;s $200 million-400 million guidance range).
With an annual dividend of $300 million, the analyst sees net debt reduction of just $100 million in 2025, bringing gross debt/EBITDA to 3.4x by year-end and increasing the risk of a credit rating downgrade to non-investment grade.
For 2026, the analyst estimates post-dividend free cash flow of $150 million, leaving FMC needing $850 million in new debt to cover $1 billion in maturing bonds.
Given these challenges, Byrne believes a dividend cut is increasingly likely possible.
Apart from this, RBC Capital analyst Arun Viswanathan downgraded FMC from Outperform to Sector Perform and lowered the price forecast from&nbsp;$78&nbsp;to&nbsp;$47.
Investors can gain exposure to the stock via&nbsp;First Trust Materials AlphaDEX Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FXZ#NYSE">FXZ</a>) and Global X AgTech &amp; Food Innovation ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KROP#NASDAQ">KROP</a>).
Price Action: FMC shares are down 34.79% at $35.23 at the last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/01/42980550/increased-demand-trump-administration-risks-analyst-picks-celanese-as-chemical-winner-adm-as-loser-for-2025" target="_blank" rel="noreferrer noopener">Increased Demand, Trump Administration Risks: Analyst Picks Celanese As Chemical Winner, ADM As Loser For 2025</a></li>
</ul>
Image via Shutterstock.

Analyst Color

Equities

Large Cap

Movers

KROP

FMC's Dividend In Danger? Analyst Warns Of Debt Pressures And Credit Downgrade Risks

U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining around 50 points on Wednesday.
The Dow traded up 0.13% to 44,612.83 while the NASDAQ fell 0.36% to 19,584.07. The S&amp;P 500 also fell, dropping, 0.09% to 6,032.63.
Check This Out: <a href="https://www.benzinga.com/25/02/43490310/top-2-health-care-stocks-that-may-crash-in-february">Top 2 Health Care Stocks That May Crash In February</a>
Leading and Lagging Sectors Real estate shares surged by 1.2% on Wednesday.
In trading on Wednesday, communication services shares fell by 3.5%.
Top Headline
The ISM services PMI fell to 52.8 in January versus a revised reading of 54 in December, and down from estimates of 54.3.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Criteo S.A. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRTO#NASDAQ">CRTO</a>) shares shot up 19% to $45.85 following better-than-expected fourth-quarter reported financial results and an increase in its share buyback authorization program.</li>
<li>Shares of Pasithea Therapeutics Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTTA#NASDAQ">KTTA</a>)got a boost, surging 44% to $3.07 after a Safety Review Committee recommended proceeding to Cohort 5 in its Phase 1 trial of PAS-004 without modification.</li>
<li>Aurora Cannabis Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) shares were also up, gaining 46% to $5.38 after the company reported a 37% year-over-year increase in third-quarter total net revenue.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Volcon Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VLCN#NASDAQ">VLCN</a>) shares dropped 42% to $1.8498 after the company announced the pricing of $12.0 million underwritten public offering.</li>
<li>Shares of FMC Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) were down 34% to $35.81 following weak guidance.</li>
<li>RXO, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RXO#NYSE">RXO</a>) was down, falling 13% to $21.90 following fourth-quarter results.</li>
</ul>
Commodities In commodity news, oil traded down 2.1% to $71.19 while gold traded up 0.4% at $2,887.10.
Silver traded down 0.4% to $32.885 on Wednesday, while copper rose 0.8% to $4.39.
Euro zone
European shares were mostly higher today. The eurozone's STOXX 600 rose 0.28%, Germany's DAX 40 gained 0.15% and France's CAC 40 fell 0.37%. Spain's IBEX 35 Index rose 1.13%, while London's FTSE 100 rose 0.41%.
Asia Pacific Markets
Asian markets closed mostly lower on Wednesday, with Japan's Nikkei 225 gaining 0.09%, China's Shanghai Composite Index falling 0.65%, Hong Kong's Hang Seng Index falling 0.93% and India's BSE Sensex falling 0.40%.
Economics
<ul>
<li>The U.S. trade deficit increased to $98.4 billion in December versus a revised $78.9 billion gap in the previous month and compared to market estimates of a $96.6 billion gap.</li>
<li>U.S. private businesses added 183,000 workers to their payrolls in January, compared to a revised 176,000 gain in December and above expectations of 150,000.</li>
<li>The S&amp;P Global composite PMI came in at 52.7 for January, versus the preliminary reading of 52.4 and compared to December's level of 55.4.</li>
<li>The ISM services PMI fell to 52.8 in January versus a revised reading of 54 in December, and down from estimates of 54.3.</li>
<li>The Energy Information Administration said crude inventories increased by 3.463 million barrels in the recent week, exceeding market estimates of a 3.2 million-barrel gain.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/02/43491430/wall-streets-most-accurate-analysts-spotlight-on-3-industrials-stocks-delivering-high-dividend-yields-2">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Industrials Stocks Delivering High-Dividend Yields</a></li>
</ul>

Eurozone

Commodities

Intraday Update

CRTO

KTTA

VLCN

Crude Oil Down 2%; ISM Services PMI Falls In January

B of A Securities analyst Steve Byrne downgrades FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) from Neutral to Underperform and lowers the price target from $61 to $48.

B of A Securities Downgrades FMC to Underperform, Lowers Price Target to $48

BMO Capital analyst Joel Jackson maintains FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) with a Market Perform and lowers the price target from $62 to $50.

BMO Capital Maintains Market Perform on FMC, Lowers Price Target to $50

U.S. stocks traded mixed this morning, with the Nasdaq Composite falling around 100 points on Wednesday.
Following the market opening Wednesday, the Dow traded up 0.08% to 44,590.52 while the NASDAQ fell 0.55% to 19,545.97. The S&amp;P 500 also fell, dropping, 0.17% to 6,027.54.
Check This Out: <a href="https://www.benzinga.com/25/02/43490310/top-2-health-care-stocks-that-may-crash-in-february">Top 2 Health Care Stocks That May Crash In February</a>
Leading and Lagging Sectors Utilities shares surged by 1.1% on Wednesday.
In trading on Wednesday, communication services shares fell by 2.6%.
Top Headline
The Walt Disney Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) reported better-than-expected first-quarter financial results.
Walt Disney reported quarterly earnings of $1.76 per share which beat the analyst consensus estimate of $1.45 per share. The company reported quarterly sales of $24.70 billion which beat the analyst consensus estimate of $24.62 billion.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Oragenics Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OGEN#NYSE">OGEN</a>) shares shot up 94% to $0.55.</li>
<li>Shares of Pasithea Therapeutics Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTTA#NASDAQ">KTTA</a>)got a boost, surging 59% to $3.32 after a Safety Review Committee recommended proceeding to Cohort 5 in its Phase 1 trial of PAS-004 without modification.</li>
<li>Aurora Cannabis Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) shares were also up, gaining 41% to $5.18 after the company reported a 37% YoY increase in third-quarter total net revenue.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Volcon Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VLCN#NASDAQ">VLCN</a>) shares dropped 39% to $1.96 after the company announced the pricing of $12.0 million underwritten public offering.</li>
<li>Shares of FMC Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) were down 36% to $34.70 following weak guidance.</li>
<li>Lottery.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LTRY#NASDAQ">LTRY</a>) was down, falling 29% to $0.42. Lottery.com recently announced an international operations expansion by targeting Europe, Africa, and other emerging markets.</li>
</ul>
Commodities In commodity news, oil traded down 1.2% to $71.86 while gold traded up 0.5% at $2,889.50.
Silver traded down 0.4% to $32.880 on Wednesday, while copper rose 0.2% to $4.3620.
Euro zone
European shares were mixed today. The eurozone's STOXX 600 rose 0.2%, Germany's DAX 40 slipped 0.1% and France's CAC 40 fell 0.2%. Spain's IBEX 35 Index rose 1.2%, while London's FTSE 100 rose 0.2%.
Asia Pacific Markets
Asian markets closed mostly lower on Wednesday, with Japan's Nikkei 225 gaining 0.09%, China's Shanghai Composite Index falling 0.65%, Hong Kong's Hang Seng Index falling 0.93% and India's BSE Sensex falling 0.40%.
Economics
<ul>
<li>The U.S. trade deficit increased to $98.4 billion in December versus a revised $78.9 billion gap in the previous month and compared to market estimates of a $96.6 billion gap.</li>
<li>U.S. private businesses added 183,000 workers to their payrolls in January, compared to a revised 176,000 gain in December and above expectations of 150,000.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/02/43491430/wall-streets-most-accurate-analysts-spotlight-on-3-industrials-stocks-delivering-high-dividend-yields-2">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Industrials Stocks Delivering High-Dividend Yields</a></li>
</ul>

LTRY

OGEN

US Stocks Mixed; Walt Disney Posts Upbeat Earnings

Morgan Stanley analyst Vincent Andrews maintains FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) with a Equal-Weight and lowers the price target from $70 to $46.

Morgan Stanley Maintains Equal-Weight on FMC, Lowers Price Target to $46

U.S. stock futures were lower this morning, with the Nasdaq futures falling over 150 points on Wednesday.
Shares of Advanced Micro Devices, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) declined 8.6% to $109.26 in pre-<a href="https://in.benzinga.com/markets/equities/25/02/43488193/amd-merges-client-gaming-segments-after-59-drop-in-gaming-revenue-aims-to-align-reporting-with-business-focus">market trading</a>.
AMD reported upbeat earnings and sales results for the fourth quarter after the market closed on Tuesday. The company expects first-quarter revenue of approximately $7.1 billion, plus or minus $300 million. At the midpoint, the revenue guidance represents year-over-year growth of approximately 30%.
Advanced Micro Devices shares dipped 8.6% to $109.26 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>FMC Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) shares fell 20.7% to $42.78 in pre-market trading following weak guidance.</li>
<li>Oscar Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OSCR#NYSE">OSCR</a>) fell 12.3% to $13.40 in pre-market trading after the company reported worse-than-expected fourth-quarter financial results and issued FY25 sales guidance below estimates.</li>
<li>Intapp, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTA#NASDAQ">INTA</a>) dipped 8.6% to $67.19 in pre-market trading after the company issued FY25 revenue guidance below estimates.</li>
<li>Match Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTCH#NASDAQ">MTCH</a>) fell 8.4% to $33.40 in pre-market trading after the company reported fourth-quarter financial results and issued first-quarter revenue guidance below estimates..</li>
<li>SunCar Technology Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDA#NASDAQ">SDA</a>) fell 6.8% to $9.60 in pre-market trading after the company announced a follow-on public offering.</li>
<li>Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) shares dipped 6.9% to $193.39 in pre-market trading. Alphabet reported better-than-expected fourth-quarter earnings, while sales missed estimates. Google Cloud revenue was up 30% year-over-year to $12 billion.</li>
<li>Chipotle Mexican Grill, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>) fell 5.2% to $55.94 in pre-market trading following mixed fourth-quarter financial results and a decline in restaurant level operating margin..</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43460681/jim-cramer-says-no-to-bigbear-ai-recommends-buying-this-tech-stock">Jim Cramer Says No To BigBear.ai, Recommends Buying This Tech Stock</a></li>
</ul>

GOOG

INTA

MTCH

OSCR

Market Index Target Term Securities Linked To The Dow Jones Industrial Average

AMD, Alphabet, Chipotle And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

WIIM

FMC shares are trading lower after RBC Capital downgraded the stock from Outperform to Sector Perform and cut its price target from $78 to $47.

RBC Capital analyst Arun Viswanathan downgrades FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) from Outperform to Sector Perform and lowers the price target from $78 to $47.

RBC Capital Downgrades FMC to Sector Perform, Lowers Price Target to $47

FMC shares are trading lower following weak guidance.

The Q4 earnings report for FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) was released on Tuesday, February 4, 2025 at 04:05 PM.
Here's what investors need to know about the latest announcement.
<h3>Earnings</h3>
FMC beat estimated earnings by 12.0%, reporting an EPS of $1.79 versus an estimate of $1.6.
Revenue was up $78.00 million from the same period last year.
<h3>Performance in Previous Earnings</h3>
The company beat on EPS by $0.16 in the previous quarter, leading to a 11.0% increase share price change the next day.
Here's a look at FMC's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.53</td>
<td>0.57</td>
<td>0.34</td>
<td>1.08</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.69</td>
<td>0.63</td>
<td>0.36</td>
<td>1.07</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>1.04B</td>
<td>1.05B</td>
<td>1.01B</td>
<td>1.25B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>1.06B</td>
<td>1.04B</td>
<td>918.00M</td>
<td>1.15B</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
FMC management provided guidance for Q1 2025, expecting earnings between $0.05 and $0.15 per share.
To track all earnings releases for FMC <a href="https://www.benzinga.com/quote/FMC/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Recap: FMC Q4 Earnings

FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) just disclosed its Q4 earnings on Tuesday, February 4, 2025 at 04:05 PM.
Here's a brief overview of the earnings report.
<h3>Earnings</h3>
FMC beat estimated earnings by 12.0%, reporting an EPS of $1.79 versus an estimate of $1.6.
Revenue was up $78.00 million from the same period last year.
<h3>Previous Earnings Records</h3>
The company beat on EPS by $0.16 in the last quarter, resulting in a 11.0% increase share price change the following day.
Here's a look at FMC's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.53</td>
<td>0.57</td>
<td>0.34</td>
<td>1.08</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.69</td>
<td>0.63</td>
<td>0.36</td>
<td>1.07</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>1.04B</td>
<td>1.05B</td>
<td>1.01B</td>
<td>1.25B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>1.06B</td>
<td>1.04B</td>
<td>918.00M</td>
<td>1.15B</td>
</tr>
</tbody>
</table>

To track all earnings releases for FMC <a href="https://www.benzinga.com/quote/FMC/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FMC Earnings Review: Q4 Summary

FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) reported its Q4 earnings results on Tuesday, February 4, 2025 at 04:05 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
FMC beat estimated earnings by 12.0%, reporting an EPS of $1.79 versus an estimate of $1.6.
Revenue was up $78.00 million from the same period last year.
<h3>Performance in Previous Earnings</h3>
Last quarter the company beat on EPS by $0.16 which was followed by a 11.0% increase in the share price the next day.
Here's a look at FMC's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.53</td>
<td>0.57</td>
<td>0.34</td>
<td>1.08</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.69</td>
<td>0.63</td>
<td>0.36</td>
<td>1.07</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>1.04B</td>
<td>1.05B</td>
<td>1.01B</td>
<td>1.25B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>1.06B</td>
<td>1.04B</td>
<td>918.00M</td>
<td>1.15B</td>
</tr>
</tbody>
</table>

To track all earnings releases for FMC <a href="https://www.benzinga.com/quote/FMC/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FMC Q4 Earnings Assessment

FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) announced its Q4 earnings on Tuesday, February 4, 2025 at 04:05 PM.
Here's a breakdown of the earnings report.
<h3>Earnings</h3>
FMC beat estimated earnings by 12.0%, reporting an EPS of $1.79 versus an estimate of $1.6.
Revenue was up $78.00 million from the same period last year.
<h3>Previous Earnings Records</h3>
During the previous quarter, the company beat on EPS by $0.16, leading to a 11.0% increase share price change the next day.
Here's a look at FMC's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.53</td>
<td>0.57</td>
<td>0.34</td>
<td>1.08</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.69</td>
<td>0.63</td>
<td>0.36</td>
<td>1.07</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>1.04B</td>
<td>1.05B</td>
<td>1.01B</td>
<td>1.25B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>1.06B</td>
<td>1.04B</td>
<td>918.00M</td>
<td>1.15B</td>
</tr>
</tbody>
</table>

To track all earnings releases for FMC <a href="https://www.benzinga.com/quote/FMC/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FMC Earnings Analysis: Q4 Recap

Legal

Press Releases

Deadline Alert: FMC Corporation (FMC) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

Class Action Filed Against FMC Corporation (FMC) - April 14, 2025 Deadline to Join – Contact The Gross Law Firm

FMC Corporation CEO Pierre Brondeau and CFO Andrew Sandifer to speak at Bank of America 2025 Global Agriculture and Materials Conference

FMC Investor News: FMC Purchasers Have Opportunity to Lead FMC Corporation Securities Fraud Lawsuit

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 14, 2025 in FMC Corporation Lawsuit - FMC

FMC Corporation (FMC) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

DEADLINE ALERT for ESTC, MRK, and FMC: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

FMC Corporation Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before April 14, 2025 to Discuss Your Rights – FMC

FMC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that FMC Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages FMC Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – FMC

ESTC

American Vanguard Corporation Common Stock ($0.10 Par Value)

American Vanguard

Bioceres Crop Solutions Corp. - Ordinary Shares

Bioceres Crop Solutions

CF Industries Holdings, Inc. Common Stock

CF Industries Holdings

Corteva

Enlightify

Brazil Potash

Intrepid Potash

Mosaic

N2OFF

Scotts Miracle-Gro Company (The) Common Stock

Scotts Miracle Gro

CVR Partners, LP Common Units representing Limited Partner Interests

Comments

FMC

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga